
Healthcare · NSE / BSE
Global Health Limited is one of the largest private multi-speciality tertiary care providers in North and East India, operating under the "Medanta" brand. The company specializes in cardiology, neurosciences, oncology, digestive sciences, orthopaedics, liver transplants, and kidney care. With hospitals in Gurugram, Indore, Ranchi, and Lucknow, it offers healthcare services across 30 medical specialities with over 1,300 doctors and 2,467 installed beds. Medanta’s Gurugram hospital was ranked India’s best private hospital from 2020 to 2022 and featured in Newsweek’s global hospital rankings. The company emphasizes clinical research, academic excellence, and advanced medical infrastructure. Its strong financial performance, presence in high-demand areas, and expansion into digital health contribute to its growth. Backed by experienced management and institutional investors, Global Health Limited continues to strengthen its position in India's healthcare sector.
Price Band
₹336
Issue Size
₹2206 Cr
Lot Size
44 shares
GMP
+9.8%
Est. Listing
₹369
at current GMP
Subscribed
9.58x
overall
Open
3 Nov 2022
Close
7 Nov 2022
Allotment
11 Nov 2022
Refund
12 Nov 2022
Demat Credit
13 Nov 2022
Listing
16 Nov 2022
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹336
Band: ₹336
Estimated Listing Price
₹369
Upper price + GMP
Lot Size
44 shares
Min investment ₹14,784
Estimated Profit / Lot
₹1,452
44 × ₹33
Grey Market Premium trend
+₹33
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹33 | 9.8% | ₹369 |
| 30 Oct 2026 | +₹33 | 9.8% | ₹369 |
| 29 Oct 2026 | +₹30 | 8.8% | ₹366 |
GMP is unofficial market data. Not a guarantee of listing performance.
Global Health Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹2,205.57 Crores. The shares are offered at a price band of ₹336 to ₹336 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2022-11-07, the basis of allotment is scheduled to be finalized on 2022-11-11. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
The latest grey market premium for Global Health Limited IPO is ₹33, which indicates an expected listing price of ₹369.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.